Cipla
Umang Vohra is the current Managing Director and Global Chief Executive Officer at Cipla. Umang has over 19 years of experience in the pharmaceutical industry. Prior to joining Cipla, they were with Dr. Reddy's Laboratories for 13 years, where they served as EVP and Head North America Generics and Corporate. Before that, they worked with Pepsico- India for 4 years as Manager- Financial Planning. Umang started their career with Eicher Ltd as Manager - Finance in 1996.
Umang Vohra has a MBA in Management from T.A. PAI MANAGEMENT INSTITUTE and a Bachelor of Engineering - BE in Computer Science from MSRIT, Bangalore.
Some direct reports include Ashok Sinha - Independent Director, Peter Mugyenyi - Independent Director, and Adil Zainulbhai - Independent Director.
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.